The global fertility test market is expected to reach USD 583.1 million by 2023 from USD 386.7 million in 2017, at a CAGR of 7.2% during the forecast period.
The time frame considered for the study is as follows:
- Base Year: 2017
- Forecast Period: 2018–2023
As of 2017, SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings (US) held the leading position in the global fertility test market. These companies adopted product launches, enhancements, and acquisitions as their key growth strategies in the past three years. include Valley Electronics (Germany), Geratherm Medical (Germany), Hilin Life Products (US), Fairhaven Health (US), Fertility Focus (UK), bioZhena (US), TaiDoc Technology (Taiwan), UEBE Medical (Germany), AdvaCare Pharma (US), Ava (Switzerland), Babystart (UK), and Sensiia (UK) are some of the other major players operating in this market.
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432
- Fertility testing devices manufacturing companies
- Distributors, suppliers, and commercial service providers
- Fertility clinics
- Research laboratories and academic institutes
- Market research and consulting firms
Growth in the market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing.
This report broadly segments the market into products, mode of purchase, application, end user, and region.
The report covers the fertility test market across four key geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global market in 2018. The decline in fertility rate, rising first-time pregnancy age, and high prevalence of PCOS (polycystic ovary syndrome) among North American women are few of the major factors contributing the large share of this regional segment.
Speak to Our Expert @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139945432
Additionally, factors such as the growing use of fertility monitoring devices for contraception, rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites are increasing the adoption of fertility test in this region. The Asia Pacific region is expected to grow at the fastest CAGR as growing number of women suffering from lifestyle disorders, rising funding/investments for the development of fertility and ovulation monitors; and manufacturers and suppliers of fertility testing products are shifting their focus towards the Asian market.